FBIOX Holdings — Select Biotechnology Portfolio
All 197 reported holdings of Select Biotechnology Portfolio (FBIOX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Krystal Biotech, Inc. | 10.58% | $557.06M |
| Abbvie, Inc. | 9.22% | $485.56M |
| Amgen, Inc. | 6.53% | $343.86M |
| Gilead Sciences, Inc. | 4.82% | $253.58M |
| Fidelity Revere Street Trust | 3.35% | $176.49M |
| Alnylam Pharmaceuticals, Inc. | 2.93% | $154.52M |
| Praxis Precision Medicines Inc. | 2.47% | $129.99M |
| Insmed, Inc. | 2.25% | $118.58M |
| Argenx SE | 2.25% | $118.25M |
| Ascendis Pharma A/s | 2.04% | $107.66M |
| Revolution Medicines, Inc. | 2.02% | $106.31M |
| Ucb SA | 2.00% | $105.07M |
| Jazz Pharmaceuticals PLC | 1.84% | $97.07M |
| Scholar Rock Holding Corp. | 1.55% | $81.37M |
| Natera, Inc. | 1.41% | $74.05M |
| Moderna, Inc. | 1.28% | $67.60M |
| Axsome Therapeutics, Inc. | 1.28% | $67.20M |
| Biogen, Inc. | 1.26% | $66.41M |
| Protagonist Therapeutics, Inc. | 1.15% | $60.50M |
| Roivant Sciences Ltd. | 1.13% | $59.45M |
| Cogent Biosciences, Inc. | 1.07% | $56.10M |
| Tango Therapeutics, Inc. | 0.98% | $51.42M |
| Celcuity, Inc. | 0.95% | $49.91M |
| Madrigal Pharmaceuticals, Inc. | 0.93% | $48.78M |
| Bridgebio Pharma, Inc. | 0.89% | $46.87M |
| Immunome, Inc. | 0.88% | $46.53M |
| United Therapeutics Corp. Del | 0.87% | $45.99M |
| Kymera Therapeutics, Inc. | 0.86% | $45.31M |
| Arrivent Biopharma, Inc. | 0.83% | $43.58M |
| Candel Therapeutics, Inc. | 0.77% | $40.38M |
| Stoke Therapeutics, Inc. | 0.76% | $39.99M |
| Dianthus Therapeutics, Inc. | 0.74% | $39.11M |
| Travere Therapeutics, Inc. | 0.72% | $37.69M |
| Ionis Pharmaceuticals, Inc. | 0.69% | $36.44M |
| Dyne Therapeutics, Inc. | 0.69% | $36.41M |
| Galderma Group AG | 0.68% | $35.73M |
| Corcept Therapeutics, Inc. | 0.67% | $35.21M |
| Cytokinetics, Inc. | 0.65% | $34.48M |
| Abivax SA | 0.64% | $33.86M |
| Trevi Therapeutics, Inc. | 0.64% | $33.58M |
| Oruka Therapeutics, Inc. | 0.63% | $32.93M |
| Apogee Therapeutics, Inc. | 0.62% | $32.75M |
| Erasca, Inc. | 0.62% | $32.53M |
| Arrowhead Pharmaceuticals, Inc. | 0.61% | $31.89M |
| Disc Medicine, Inc. | 0.60% | $31.64M |
| Crinetics Pharmaceuticals, Inc. | 0.60% | $31.53M |
| Kiniksa Pharmaceuticals International PLC | 0.59% | $30.85M |
| Nuvalent, Inc. | 0.57% | $30.18M |
| Bio Ab Holdings LLC | 0.57% | $30.08M |
| Spyre Therapeutics, Inc. | 0.56% | $29.63M |
| Annexon, Inc. | 0.52% | $27.55M |
| Intellia Therapeutics, Inc. | 0.51% | $26.94M |
| Vaxcyte, Inc. | 0.46% | $24.40M |
| Edgewise Therapeutics, Inc. | 0.45% | $23.89M |
| Viridian Therapeutics, Inc. | 0.44% | $23.05M |
| Arcus Biosciences, Inc. | 0.41% | $21.61M |
| Structure Therapeutics, Inc. | 0.40% | $21.32M |
| Viatris, Inc. | 0.40% | $20.98M |
| Allogene Therapeutics, Inc. | 0.39% | $20.72M |
| Bicara Therapeutics, Inc. | 0.39% | $20.55M |
| Maze Therapeutics, Inc. | 0.37% | $19.57M |
| Zealand Pharma A/s | 0.36% | $19.17M |
| Solid Biosciences, Inc. | 0.36% | $19.13M |
| Xenon Pharmaceuticals, Inc. | 0.36% | $18.91M |
| Ideaya Biosciences, Inc. | 0.36% | $18.80M |
| Summit Therapeutics, Inc. | 0.36% | $18.73M |
| Vor Biopharma, Inc. | 0.34% | $17.75M |
| Newamsterdam Pharma Company NV | 0.33% | $17.64M |
| Mirum Pharmaceuticals, Inc. | 0.33% | $17.32M |
| Rapport Therapeutics, Inc. | 0.32% | $16.92M |
| Twist Bioscience Corp. | 0.30% | $15.97M |
| Biohaven Ltd. | 0.30% | $15.95M |
| Amylyx Pharmaceuticals, Inc. | 0.30% | $15.74M |
| Mannkind Corp. | 0.29% | $15.38M |
| Kailera Therapeutics, Inc. | 0.27% | $14.21M |
| Relay Therapeutics, Inc. | 0.27% | $14.20M |
| Uniqure N.v. | 0.26% | $13.50M |
| Enliven Therapeutics, Inc. | 0.26% | $13.46M |
| Alumis, Inc. | 0.25% | $13.39M |
| Viking Therapeutics, Inc. | 0.25% | $13.24M |
| Replimune Group, Inc. | 0.25% | $13.16M |
| Tectonic Therapeutic, Inc. | 0.24% | $12.63M |
| Idorsia Ltd. | 0.24% | $12.44M |
| Mineralys Therapeutics, Inc. | 0.23% | $12.16M |
| Ptc Therapeutics, Inc. | 0.23% | $11.85M |
| Triveni Bio, Inc. | 0.22% | $11.74M |
| Damora Therapeutics, Inc. | 0.21% | $11.31M |
| Tyra Biosciences, Inc. | 0.21% | $11.26M |
| Hemab Therapeutics Holdings, Inc. | 0.21% | $10.82M |
| Forte Biosciences, Inc. | 0.20% | $10.75M |
| Eikon Therapeutics, Inc. | 0.20% | $10.56M |
| Absci Corp. | 0.20% | $10.40M |
| Capricor Therapeutics, Inc. | 0.19% | $10.01M |
| City Therapeutics, Inc. | 0.19% | $10.00M |
| Cytomx Therapeutics, Inc. | 0.19% | $9.99M |
| Gubra A/s | 0.18% | $9.26M |
| Immunovant, Inc. | 0.17% | $9.06M |
| Rhythm Pharmaceuticals, Inc. | 0.17% | $8.81M |
| Vtv Therapeutics, Inc. | 0.16% | $8.68M |
| Beone Medicines Ltd. | 0.16% | $8.55M |
| Nuvation Bio, Inc. | 0.16% | $8.41M |
| Hansa Biopharma Ab | 0.16% | $8.36M |
| Immunocore Holdings PLC | 0.16% | $8.30M |
| Olema Pharmaceuticals, Inc. | 0.16% | $8.28M |
| Fidelity Revere Street Trust | 0.16% | $8.22M |
| Beam Therapeutics, Inc. | 0.15% | $8.07M |
| Cg Oncology, Inc. | 0.15% | $8.02M |
| Sensorion SA | 0.15% | $8.01M |
| Ocular Therapeutix, Inc. | 0.13% | $7.06M |
| Zenas Biopharma, Inc. | 0.13% | $7.00M |
| Geron Corp. | 0.13% | $6.82M |
| Jade Biosciences, Inc. | 0.13% | $6.77M |
| Immuneering Corp. | 0.12% | $6.32M |
| Biontech SE | 0.12% | $6.23M |
| Candid Therapeutics | 0.12% | $6.18M |
| X4 Pharmaceuticals, Inc. | 0.12% | $6.16M |
| Nurix Therapeutics, Inc. | 0.11% | $5.92M |
| Aktis Oncology, Inc. | 0.11% | $5.88M |
| Camp4 Therapeutics Corp. | 0.11% | $5.82M |
| Odyssey Therapeutics, Inc. | 0.11% | $5.77M |
| Cardurion Pharmaceuticals, Inc. | 0.11% | $5.64M |
| Design Therapeutics, Inc. | 0.11% | $5.61M |
| Tg Therapeutics, Inc. | 0.11% | $5.55M |
| Taysha Gene Therapies, Inc. | 0.10% | $5.52M |
| Crescent Biopharma, Inc. | 0.10% | $5.42M |
| Camp4 Therapeutics Corp. | 0.10% | $5.38M |
| Lb Pharmaceuticals, Inc. | 0.10% | $5.25M |
| Prothena Corp. PLC | 0.10% | $5.04M |
| Zenas Biopharma, Inc. | 0.09% | $4.84M |
| Neurona Therapeutics, Inc. | 0.09% | $4.74M |
| Pharvaris Bv | 0.08% | $4.46M |
| Denali Therapeutics, Inc. | 0.08% | $4.32M |
| Scorpion Therapeutics, Inc. | 0.08% | $4.29M |
| Sana Biotechnology, Inc. | 0.08% | $4.17M |
| Vera Therapeutics, Inc. | 0.07% | $3.87M |
| Sionna Therapeutics, Inc. | 0.07% | $3.46M |
| Parabilis Medicines, Inc. | 0.06% | $3.38M |
| Tubulis Gmbh | 0.06% | $3.36M |
| Ars Pharmaceuticals, Inc. | 0.06% | $3.04M |
| Janux Therapeutics, Inc. | 0.06% | $3.02M |
| Alector, Inc. | 0.06% | $2.98M |
| Cartesian Therapeutics, Inc. | 0.05% | $2.76M |
| Moonlake Immunotherapeutics | 0.05% | $2.75M |
| National Resilience, Inc. | 0.05% | $2.48M |
| Shattuck Labs, Inc. | 0.04% | $2.33M |
| Mbx Biosciences, Inc. | 0.04% | $2.30M |
| Vertex Pharmaceuticals, Inc. | 0.04% | $2.29M |
| Wave Life Sciences Ltd. | 0.04% | $2.27M |
| Gh Research PLC | 0.04% | $2.22M |
| Zura Bio Ltd. | 0.04% | $2.19M |
| Bridgebio Oncology Therapeutic | 0.04% | $2.16M |
| Veradermics, Inc. | 0.04% | $2.10M |
| Kardigan, Inc. | 0.04% | $2.00M |
| Cellcentric Ltd. | 0.04% | $1.99M |
| Palvella Therapeutics, Inc. | 0.04% | $1.98M |
| Upstream Bio, Inc. | 0.04% | $1.96M |
| Cartesian Therapeutics, Inc. | 0.03% | $1.56M |
| Foghorn Therapeutics, Inc. | 0.03% | $1.50M |
| Neurogene, Inc. | 0.03% | $1.45M |
| Atea Pharmaceuticals, Inc. | 0.03% | $1.34M |
| Anaptysbio, Inc. | 0.02% | $1.30M |
| Zymeworks Delaware, Inc. | 0.02% | $1.20M |
| Lexicon Pharmaceuticals, Inc. | 0.02% | $1.12M |
| Perspective Therapeutics, Inc. | 0.02% | $1.02M |
| Atyr Pharma, Inc. | 0.02% | $951.87K |
| Legend Biotech Corp. | 0.02% | $888.40K |
| Tarsus Pharmaceuticals, Inc. | 0.01% | $683.10K |
| Cyclerion Therapeutics, Inc. | 0.01% | $644.53K |
| Biomea Fusion, Inc. | 0.01% | $624.67K |
| Regeneron Pharmaceuticals, Inc. | 0.01% | $614.78K |
| Septerna, Inc. | 0.01% | $585.88K |
| Harmony Biosciences Holdings, Inc. | 0.01% | $553.61K |
| Belite Bio, Inc. | 0.01% | $446.96K |
| Inmed Pharmaceuticals, Inc. | 0.01% | $441.67K |
| Korro Bio, Inc. | 0.01% | $440.73K |
| Avalyn Pharma, Inc. | 0.01% | $431.70K |
| Elevatebio, LLC | 0.01% | $398.54K |
| First Tracks Biotherapeutics, Inc. | 0.01% | $371.87K |
| Biocryst Pharmaceuticals, Inc. | 0.01% | $337.52K |
| Lenz Therapeutics, Inc. | 0.01% | $296.09K |
| Antares Therapeutics, Inc. | 0.01% | $296.20K |
| Generate Biomedicine, Inc. | 0.01% | $286.02K |
| Keros Therapeutics, Inc. | 0.01% | $276.50K |
| Seaport Therapeutics, Inc. | 0.00% | $231.01K |
| Novocure Ltd. | 0.00% | $189.37K |
| Bioxcel Therapeutics, Inc. | 0.00% | $105.65K |
| Blue Marlin Therapeutics, Inc. | 0.00% | $102.25K |
| Inhibikase Therapeutics, Inc. | 0.00% | $98.47K |
| Ultragenyx Pharmaceutical, Inc. | 0.00% | $83.53K |
| Foghorn Therapeutics, Inc. | 0.00% | $77.42K |
| Myos Corp. | 0.00% | $41.67K |
| Optinose, Inc. | 0.00% | $1 |
| Biomea Fusion, Inc. | 0.00% | $857 |
| Chinook Therapeutics, Inc. | 0.00% | $1 |
| Afferent Pharma | 0.00% | $83 |
| Medavail Holdings, Inc. | 0.00% | $0 |
| Axcella Health, Inc. | 0.00% | $1 |
FBIOX overview: performance, fees, allocation and SEC filings